Metabolomics in Personalized medicine
The ability of biomarkers to improve treatment and reduce healthcare costs is potentially greater than in any other area of current medical research. For example, the American Society of Clinical Oncology estimates that routinely testing people with colon cancer for mutations in the K-RAS oncogene would save at least US $600 million a years.
Related Conference of Metabolomics in Personalized medicine
June 22-23, 2026
5th World Congress on Medicinal Chemistry and Computer Aided Drug Design
Paris, France
July 27-28, 2026
19th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Rome, Italy
July 27-28, 2026
26th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
Rome, Italy
August 20-21, 2026
27th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
London, UK
August 20-21, 2026
29th International Conference and Exhibition on Pharmaceutical Formulations
London, UK
August 20-21, 2026
32nd International Conference on Advanced Clinical Research and Clinical Trials
London, UK
November 19-20, 2026
14th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Dubai, UAE
November 26-27, 2026
5th World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland